Skip to content
Search

Latest Stories

RPS launches new policy on AI in pharmacy practice

The opportunities, challenges and potential applications of AI within pharmacy
gettyimages

AI technologies have the potential to transform the way that pharmacists and pharmacy teams work

The Royal Pharmaceutical Society (RPS) has published a new policy outlining how artificial intelligence (AI) can be used to support pharmacy practice and improve patient care.

The content has been developed in consultation with RPS members, Expert Advisory Group members, Board members, multi-professional experts in digital technology and AI, and external stakeholders including the General Pharmaceutical Council (GPhC).


The policy highlights the opportunities, challenges and potential applications of AI within pharmacy now and in the future.

RPS President, Professor Claire Anderson, acknowledges that AI technologies have the potential to transform pharmacy practice, noting that “there are some great examples where it’s already in use.”

“We must optimise the opportunities that these advancing technologies can bring to enhance patient access to care, improve patient experience, support clinical decision making and improve the safety and efficiency of the medicines supply chain.

“Our policy provides a framework to ensure AI is harnessed safely and effectively to support pharmacists and patients,” she adds.

Key areas of the policy include:

  • Improving patient care: AI is a tool to support pharmacy professionals to improve the safe and effective use of medicines in any setting, and achieve better patient outcomes
  • Education and training: Investment in AI skills and knowledge is vital to equip the pharmacy workforce for the future
  • Data protection: Pharmacists must safeguard patient data and ensure compliance with privacy standards when using AI tools
  • Collaboration: AI tools must be developed in partnership with pharmacists, data scientists, developers and patients and to ensure they meet clinical needs
  • Governance and safety: AI systems must adhere to strict regulatory standards, with ongoing testing and oversight to safeguard patients
  • Patient focus: Transparency and diverse data are essential to ensure fair and effective AI-driven care.

Will AI lead to job displacement?

The RPS says that AI will enhance job roles, rather than replace them.

The organisation explains: “The automation of routine tasks could allow all staff to take on a more patient-centred focus and ultimately improve patient care.

“While AI will radically alter how work gets done and who does it, the larger impact will be in complementing and augmenting human capabilities, not replacing them.”

More For You

Infant formula: Food, diet and obesity committee welcomes CMA proposals, demands action on processed foods
CMA study shows that parents could save around £300 a year by switching to a lower priced infant formula brand (gettyimages)

Infant formula: CMA calls for stronger labelling and advertising rules

All infant formula brands should be displayed together and separately from other formula milks in stores to enable quick and easy price comparisons – suggests CMA 

The Competition and Marketing Authority (CMA) has recommended the governments of the four UK nations to strengthen advertising and labelling rules of infant formula to help parents make informed decisions and save money.

This follows a CMA study on infant formula and follow-on milks, which found that a combination of factors was leading to poor outcomes for parents.

Keep ReadingShow less
David Thomas Steps In as NPA’s New Wales Representative
Five NPA members are contesting for the remaining position in England (gettyimages)

NPA board update: David Thomas succeeds Raj Aggarwal OBE

Five NPA members are contesting for the remaining position in England

David Thomas, owner of LT Chemists in Newport, will replace Raj Aggarwal OBE as the next National Pharmacy Association (NPA) board member for Wales, following an uncontested election this month.

Following the conclusion of a nomination process last week, Baldev Bange, Aisling O’Brien, Sehar Shahid, and Sanjay Ganvir have been re-elected to the Board, representing areas of England and Scotland, according to a statement from NPA.

Keep ReadingShow less
Public Policy Projects calls for better use of community pharmacy skill mix to improve medicines adherence
Non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed. (gettyimages)

Leverage pharmacy skill mix to improve medicines adherence - report suggests

The report also suggested expanding the community pharmacy contractual framework to enable community pharmacy to deliver medicines reviews

Pharmacy technicians and assistants should be enabled to talk to patients about their medications to improve medicines adherence, a new report has recommended.

The report, How medicines optimisation contributes to population health, published recently by policy institute Public Policy Projects, highlighted that non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed.

Keep ReadingShow less
GHP calls for 10% mandated protected learning time for NHS pharmacists in new campaign
Many pharmacists end up doing ‘unpaid work’ to catch up with the required training (gettyimages)

Increase protected learning time for NHS pharmacists – GHP launches national campaign

Many pharmacists end up doing ‘unpaid work’ to catch up with the required training or completing self-learning in their own time.

The Guild of Healthcare Pharmacists (GHP) has launched a national campaign advocating for pharmacists working in the NHS to have a minimum of 10% of their contracted hours protected for supporting professional activities (SPA).

In a statement published on 7 February 2025, the GHP emphasised that this protected time “should be recognized by employers and embedded in job plans.”

Keep ReadingShow less
Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Kinnock confirms that an announcement on the 2025/26 GP contract would be made before April 2025

The 2025/26 pharmacy contract consultation will include a review of the medicine margin and reimbursement arrangements, health and care minister Stephen Kinnock has confirmed.

Kinnock made this statement in response to a written question from Nick Timothy, Conservative MP for West Suffolk, who asked the secretary of state for health and social care, if he will review the reimbursement system for pharmacies and GP practices dispensing medicines.

Keep ReadingShow less